Global Immuno-oncology Therapy Market Professional Survey Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Immuno-oncology Therapy Revenue
• 1.4 Market by Type
  • 1.4.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Monoclonal Antibodies
  • 1.4.3 Immune Checkpoint Inhibitors
  • 1.4.4 Immune System Modulators
  • 1.4.5 Cancer Vaccines
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Immuno-oncology Therapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Ambulatory Surgical Center
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Immuno-oncology Therapy Market Perspective (2015-2026)
• 2.2 Global Immuno-oncology Therapy Growth Trends by Regions
  • 2.2.1 Immuno-oncology Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Immuno-oncology Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Immuno-oncology Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Immuno-oncology Therapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Immuno-oncology Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Immuno-oncology Therapy Players by Market Size
  • 3.1.1 Global Top Immuno-oncology Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Immuno-oncology Therapy Market Concentration Ratio
  • 3.2.1 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Immuno-oncology Therapy Revenue in 2019
• 3.3 Immuno-oncology Therapy Key Players Head office and Area Served
• 3.4 Key Players Immuno-oncology Therapy Product Solution and Service
• 3.5 Date of Enter into Immuno-oncology Therapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Immuno-oncology Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Immuno-oncology Therapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Immuno-oncology Therapy Market Size by Application (2015-2020)
• 5.2 Global Immuno-oncology Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Immuno-oncology Therapy Market Size (2015-2020)
• 6.2 Immuno-oncology Therapy Key Players in North America (2019-2020)
• 6.3 North America Immuno-oncology Therapy Market Size by Type (2015-2020)
• 6.4 North America Immuno-oncology Therapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Immuno-oncology Therapy Market Size (2015-2020)
• 7.2 Immuno-oncology Therapy Key Players in Europe (2019-2020)
• 7.3 Europe Immuno-oncology Therapy Market Size by Type (2015-2020)
• 7.4 Europe Immuno-oncology Therapy Market Size by Application (2015-2020)

8 China

• 8.1 China Immuno-oncology Therapy Market Size (2015-2020)
• 8.2 Immuno-oncology Therapy Key Players in China (2019-2020)
• 8.3 China Immuno-oncology Therapy Market Size by Type (2015-2020)
• 8.4 China Immuno-oncology Therapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Immuno-oncology Therapy Market Size (2015-2020)
• 9.2 Immuno-oncology Therapy Key Players in Japan (2019-2020)
• 9.3 Japan Immuno-oncology Therapy Market Size by Type (2015-2020)
• 9.4 Japan Immuno-oncology Therapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Immuno-oncology Therapy Market Size (2015-2020)
• 10.2 Immuno-oncology Therapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Immuno-oncology Therapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Immuno-oncology Therapy Market Size by Application (2015-2020)

11 India

• 11.1 India Immuno-oncology Therapy Market Size (2015-2020)
• 11.2 Immuno-oncology Therapy Key Players in India (2019-2020)
• 11.3 India Immuno-oncology Therapy Market Size by Type (2015-2020)
• 11.4 India Immuno-oncology Therapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Immuno-oncology Therapy Market Size (2015-2020)
• 12.2 Immuno-oncology Therapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Immuno-oncology Therapy Market Size by Type (2015-2020)
• 12.4 Central & South America Immuno-oncology Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Amgen
  • 13.1.1 Amgen Company Details
  • 13.1.2 Amgen Business Overview
  • 13.1.3 Amgen Immuno-oncology Therapy Introduction
  • 13.1.4 Amgen Revenue in Immuno-oncology Therapy Business (2015-2020))
  • 13.1.5 Amgen Recent Development
• 13.2 AstraZeneca
  • 13.2.1 AstraZeneca Company Details
  • 13.2.2 AstraZeneca Business Overview
  • 13.2.3 AstraZeneca Immuno-oncology Therapy Introduction
  • 13.2.4 AstraZeneca Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.2.5 AstraZeneca Recent Development
• 13.3 Bristol-Myers Squibb
  • 13.3.1 Bristol-Myers Squibb Company Details
  • 13.3.2 Bristol-Myers Squibb Business Overview
  • 13.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Introduction
  • 13.3.4 Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.3.5 Bristol-Myers Squibb Recent Development
• 13.4 Eli-Lilly
  • 13.4.1 Eli-Lilly Company Details
  • 13.4.2 Eli-Lilly Business Overview
  • 13.4.3 Eli-Lilly Immuno-oncology Therapy Introduction
  • 13.4.4 Eli-Lilly Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.4.5 Eli-Lilly Recent Development
• 13.5 Roche
  • 13.5.1 Roche Company Details
  • 13.5.2 Roche Business Overview
  • 13.5.3 Roche Immuno-oncology Therapy Introduction
  • 13.5.4 Roche Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.5.5 Roche Recent Development
• 13.6 GlaxoSmithKline
  • 13.6.1 GlaxoSmithKline Company Details
  • 13.6.2 GlaxoSmithKline Business Overview
  • 13.6.3 GlaxoSmithKline Immuno-oncology Therapy Introduction
  • 13.6.4 GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.6.5 GlaxoSmithKline Recent Development
• 13.7 Janssen Biotech
  • 13.7.1 Janssen Biotech Company Details
  • 13.7.2 Janssen Biotech Business Overview
  • 13.7.3 Janssen Biotech Immuno-oncology Therapy Introduction
  • 13.7.4 Janssen Biotech Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.7.5 Janssen Biotech Recent Development
• 13.8 Merck
  • 13.8.1 Merck Company Details
  • 13.8.2 Merck Business Overview
  • 13.8.3 Merck Immuno-oncology Therapy Introduction
  • 13.8.4 Merck Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.8.5 Merck Recent Development
• 13.9 Novartis
  • 13.9.1 Novartis Company Details
  • 13.9.2 Novartis Business Overview
  • 13.9.3 Novartis Immuno-oncology Therapy Introduction
  • 13.9.4 Novartis Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.9.5 Novartis Recent Development
• 13.10 Pfizer
  • 13.10.1 Pfizer Company Details
  • 13.10.2 Pfizer Business Overview
  • 13.10.3 Pfizer Immuno-oncology Therapy Introduction
  • 13.10.4 Pfizer Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 13.10.5 Pfizer Recent Development
• 13.11 Sanofi
  • 10.11.1 Sanofi Company Details
  • 10.11.2 Sanofi Business Overview
  • 10.11.3 Sanofi Immuno-oncology Therapy Introduction
  • 10.11.4 Sanofi Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 10.11.5 Sanofi Recent Development
• 13.12 Spectrum Pharmaceuticals
  • 10.12.1 Spectrum Pharmaceuticals Company Details
  • 10.12.2 Spectrum Pharmaceuticals Business Overview
  • 10.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Introduction
  • 10.12.4 Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 10.12.5 Spectrum Pharmaceuticals Recent Development
• 13.13 Takeda
  • 10.13.1 Takeda Company Details
  • 10.13.2 Takeda Business Overview
  • 10.13.3 Takeda Immuno-oncology Therapy Introduction
  • 10.13.4 Takeda Revenue in Immuno-oncology Therapy Business (2015-2020)
  • 10.13.5 Takeda Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer